Cargando…
Impact of Morbid Obesity and Obesity Phenotype on Outcomes After Transcatheter Aortic Valve Replacement
BACKGROUND: There is a paucity of outcome data on patients who are morbidly obese (MO) undergoing transcatheter aortic valve replacement. We aimed to determine their periprocedural and midterm outcomes and investigate the impact of obesity phenotype. METHODS AND RESULTS: Consecutive patients who are...
Ejemplares similares
-
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes
por: Alperi, Alberto, et al.
Publicado: (2021) -
The path of transcatheter aortic valve implantation: from compassionate to low-risk cases
por: Tamburino, Corrado, et al.
Publicado: (2020) -
Targeting Energy Expenditure—Drugs for Obesity Treatment
por: Jimenez-Munoz, Carlos M., et al.
Publicado: (2021) -
Effectiveness of a polyphenolic extract (Lippia citriodora and Hibiscus sabdariffa) on appetite regulation in overweight and obese grade I population: an 8-week randomized, double-blind, cross-over, placebo-controlled trial
por: Serna, Ana, et al.
Publicado: (2021) -
Obesity Pillars Roundtable: Obesity and Diversity
por: Bays, Harold Edward, et al.
Publicado: (2022)